The Study of Lipo-Doxorubicin Therapy forBladder Cancer
碩士 === 國立臺灣科技大學 === 醫學工程研究所 === 102 === Doxorubicin is commonly used in the treatment of superficial bladder cancer, but higher side effects and shorter intracellular retention time hampered its clinical application. While lipo-Doxorubicin (Lipo-DoxR) has the advantages of increased half-life and re...
| Main Authors: | , |
|---|---|
| Other Authors: | |
| Format: | Others |
| Language: | zh-TW |
| Published: |
2014
|
| Online Access: | http://ndltd.ncl.edu.tw/handle/42767408815194457047 |